Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Cellular Redox Balance and Tissue Injury: Study Summary

Previous related pageVitamin D, Cellular Redox Balance and Tissue Injury: Full Evidence ReviewNext related pageVitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review
Study at a glance

How were vitamin D-related compounds tested for eye and kidney cell damage?

Researchers tested vitamin D-related compounds in laboratory cells and mice. One study exposed retinal cells from the eye to hydrogen peroxide and tested calcitriol, the active vitamin D hormone. Another tested paricalcitol, a drug that activates the vitamin D receptor, in kidney cells exposed to high glucose and in mice with diabetes.

Did the tested compounds reduce signs of eye and kidney damage?

Several measurements showed less damage from reactive chemicals in the retinal-cell model, although not every protective response increased clearly. The kidney experiments showed improvements in damage linked with reactive chemicals and iron. Treated mice also had better results on urine protein loss and tissue injury. These findings concern the tested models, not human treatment outcomes.

Did tests explain how the cell protection happened?

In kidney cells, reducing Nrf2, a molecule that helps control protective responses, removed or weakened the protection. This supports its importance in those cells. The retinal study did not test whether Nrf2 or another proposed signalling substance was required. Some earlier steps proposed for the proposed process in the kidney were also not directly established. Changes occurring together are weaker evidence than interrupting a process and observing the result.

Do the findings establish protection for human eyes or kidneys?

The cell experiments do not prove that the same mechanism explains every result in mice. Changes in mouse weight and glucose could also affect kidney injury. Better appearance of structures inside cells does not establish complete recovery of their function or reversal of cellular ageing. Calcitriol and paricalcitol are not ordinary vitamin D3 supplements. Human benefits, long-term protection and a supplement dose remain unestablished.

Read the full article below ↓

Vitamin D-related compounds improved redox and injury measurements in experimental retinal and kidney models. The studies differed in how directly they tested the mechanism: the retinal study showed coordinated changes, while the kidney study used Nrf2 knockdown to test dependence. Neither establishes that ordinary vitamin D supplementation prevents retinal or kidney disease in people. Read the companion Vitamin D, Cellular Redox Balance and Tissue Injury: Full Evidence Review.

Retinal cells under oxidative challenge

Tohari and colleagues exposed ARPE-19 retinal pigment epithelial cells to hydrogen peroxide and studied calcitriol. Several measurements indicated less oxidative injury and altered antioxidant responses. NRF2 and IL-33-related expression also changed.

However, the researchers did not remove or block NRF2 or IL-33 to show that either was necessary for the protection. GPX1 did not show a clear increase in the reported experiment. The result therefore supports a protective response in the cell model, not activation of every antioxidant mechanism.

This is evidence relevant to Vitamin D and Oxidative Stress. It is not a clinical trial, and the laboratory concentration cannot be converted into a personal supplement dose.

Kidney cells and diabetic mice

Wang and colleagues studied paricalcitol, a vitamin D receptor agonist, in high-glucose-exposed HK-2 cells and diabetic mice. Redox, iron-handling and ferroptosis-related measurements improved in the reported experiments. Treated mice also showed improvements in albuminuria and tissue-injury measurements.

Reducing Nrf2 with small interfering RNA removed or attenuated the protective cellular response. This provides stronger evidence of pathway dependence than observing increased Nrf2 alone. The dependency was tested in cells, however, and should not be extended into proof that Nrf2 explained every animal outcome.

The proposed upstream VDR: Nrf2 binding step was less directly established. Predicted binding and colocalisation are not equivalent to direct promoter-binding evidence. Paricalcitol also affected weight and glucose in the mice, complicating attribution of kidney protection solely to a direct renal mechanism. A separate study by He and colleagues added VDR loss/gain experiments and direct GPX4 promoter-binding tests. It supports a complementary renal mechanism, without proving nutritional vitamin D efficacy or Wang’s proposed VDR: Nrf2 binding step.

What the measurements do not mean

Improved mitochondrial appearance is relevant to Vitamin D and Mitochondrial Function, but it does not establish complete restoration of mitochondrial function. Reduced oxidative injury likewise does not prove reversal of cellular senescence, the distinct process discussed in Vitamin D and Cellular Senescence. Those outcomes require their own measurements.

Calcitriol and paricalcitol are different experimental agents. Their effects in cells and mice do not establish a nutritional vitamin D3 treatment effect. Vitamin D Status vs Vitamin D Effect helps distinguish a circulating status measurement from the biological response tested in a particular tissue model.

The studies are related to Vitamin D and Inflammatory Signalling, but they do not prove that every protective redox effect was caused by inflammatory suppression. Vitamin D Signalling Pathways helps explain the receptor-pathway question, while Why Vitamin D Results Differ provides context for comparing different agents, tissues and exposure conditions without treating them as equivalent clinical tests.

Conclusion

The evidence supports experimental redox protection with different levels of mechanistic certainty. The retinal study is mainly associative at the pathway level; the kidney study adds a cellular Nrf2-dependency test and animal tissue outcomes. Human efficacy, long-term benefit and a supplementation regimen remain unestablished.

This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.

Primary source and publication details

Related reading

Original sources

Source

Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells

In the current study, we investigated the impact of VITD on H2O2-induced oxidative stress and inflammation in human RPE cells.

Publication details

Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells. Ali Mohammad Tohari, Reem Hasaballah Alhasani, Lincoln Biswas, Sarita Rani Patnaik, James Reilly, Zhihong Zeng, Xinhua Shu. Antioxidants; 2019; 8; 9; 341. DOI: 10.3390/antiox8090341. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy

VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy.

Publication details

VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy. Hui Wang, Xiaoyue Yu, Dongwei Liu, Yingjin Qiao, Jinling Huo, Shaokang Pan, Lijuan Zhou, Rui Wang, Qi Feng, Zhangsuo Liu. Advanced Science; 2024; 11; 10; 2305563. DOI: 10.1002/advs.202305563. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy

PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy.

Publication details

PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy. Qiongyao He, Wu He, Yanlin Ren, Wenbin Wu, Hui Dong, Gang Yuan, Huihui Ren, Xinwei Wang, Fuer Lu, Dingkun Wang. Cell Communication and Signaling : CCS; 2025; 23; 242. DOI: 10.1186/s12964-025-02253-5. CC BY-NC-ND; linked here for brief factual context only.

Read more →